The role of cytokines in the formation and prediction of refractory neprotic syndrome in membranous nepropathy
- 26 January 2026
- journal article
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 29 (4)
Abstract
BACKGROUND . The lack of reliable methods for predicting the development of treatment-refractory membranous nephropathy (MNP) with nephrotic syndrome (NS) is due to a lack of understanding of the mechanisms of NS resistance to treatment.THE AIM: to study the features of the cytokine status in patients with MNP and their significance in the formation and prediction of refractory NS. PATIENTS AND METHODS . The study was prospective and included a cohort of patients with MPN who were admitted to the nephrology department with active NS and were subsequently followed up for 24 months in the nephrologist's office at the polyclinic. The study endpoint was the completion of the 24-month follow-up period, during which the study group was divided into two subgroups based on their response to treatment: a subgroup of patients with treatment-responsive NS and a subgroup of patients with treatment-refractory NS. At the beginning of treatment and after 24 months, blood and urine samples were collected to determine the levels of cytokines IL-2, IL-4, IL-8, IL-10, and IL-17A, which were stored at -70°C until analysis. The levels of cytokines were determined simultaneously using enzyme-linked immunosorbent assay at the end of treatment. RESULTS . The study included 136 patients with MNP: 98 patients with the debut of NS, 25 with persistent NS, and 13 with frequent NS relapses. After 24 months of follow-up, 78 patients were found to have NS remission. 58 patients were refractory to treatment. In patients with refractory NS, blood and urine samples showed increased baseline levels of pro-inflammatory cytokines IL-8 and IL-17A and decreased levels of IL-10 compared to those in patients who achieved disease remission. CONCLUSION . According to the results of the study, the initial normalized by creatinine levels of IL-8 and IL-17A in the urine can be used as biomarkers for early prediction of refractory NS in MPNKeywords
This publication has 16 references indexed in Scilit:
- Kidney Tubular Biomarkers in Type 1 Diabetes - Longitudinal Analysis of 2 CohortsKidney International Reports, 2025
- Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA RegistryNephrology Dialysis Transplantation, 2024
- Prevalence of Chronic Kidney Disease in ChinaJAMA Internal Medicine, 2023
- Interleukin-8: An evolving chemokineCytokine, 2022
- Interleukin-17 family members in health and diseaseInternational Immunology, 2021
- Membranous nephropathyNature Reviews Disease Primers, 2021
- Membranous Nephropathy: Core Curriculum 2021American Journal of Kidney Diseases, 2021
- Prevalence and Disease Burden of Chronic Kidney Disease2019
- Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritisJCI Insight, 2019
- Interleukin-8 and Tumor Necrosis Factor-Alpha Are Increased in Minimal Change Disease but Do Not Alter Albumin PermeabilityAmerican Journal of Nephrology, 2003